Trial intelligence / Profile preview

BQ-123 in STEMI

NCT00502528Phase 2Completed

Sponsor
Medical University of Vienna
Start
May 2007
Primary completion
Aug 2009
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of BQ-123 in ST elevation myocardial infarction (STEMI), sponsored by Medical University of Vienna. Started May 2007; status: completed.

02

Drugs

BQ-123
03

Conditions

ST elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT00502528.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00502528.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call